Intracellular Th

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$175,159
$161,388
$144,866
$131,506
Gross Profit
159,855
150,034
134,966
120,804
EBITDA
-38,849
-27,594
-20,820
-33,961
EBIT
-38,987
-27,723
-20,952
-34,097
Net Income
-26,324
-16,219
-15,247
-28,579
Net Change In Cash
175,159
161,388
144,866
131,506
Free Cash Flow
-27,221
489
-34,116
-2,062
Cash
464,312
695,056
141,569
147,767
Basic Shares
105,768
103,723
96,875
96,285

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$464,370
$249,132
$81,707
$22,530
Gross Profit
430,625
228,689
73,673
20,635
EBITDA
-158,853
-262,970
-285,154
-230,699
EBIT
-159,381
-263,626
-285,688
-231,227
Net Income
-139,674
-256,256
-284,125
-227,005
Net Change In Cash
464,370
249,132
81,707
22,530
Cost of Revenue
56,600
32,319
-46,190
Free Cash Flow
-124,468
-270,964
-259,869
-230,339
Cash
147,767
148,615
92,364
60,045
Basic Shares
95,881
94,046
81,253
70,364

Earnings Calls

Quarter EPS
2024-09-30
-$0.25
2024-06-30
-$0.16
2024-03-31
-$0.16
2023-12-31
-$0.30